Medicare Enrolled
Dr. Neil Gilbert, M.D.
Neurology · Lathrup Village, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gilbert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gilbert?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gilbert
Dr. Neil Gilbert is a neurology specialist in Lathrup Village, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gilbert performed 9,119 Medicare services across 2,050 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gilbert received a total of $24,485 from 74 pharmaceutical and/or device companies across 1379 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gilbert is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in MI
$24,485 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,119
Medicare services
Top 5% in MI for neurology
2,050
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~456 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,090 | $0 | $1 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,241 | $66 | $90 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
883 | $94 | $145 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
265 | $109 | $170 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
177 | $78 | $162 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
175 | $11 | $30 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
152 | $97 | $120 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
150 | $1 | $10 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
136 | $11 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
129 | $145 | $200 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
109 | $305 | $645 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
94 | $145 | $230 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
93 | $74 | $165 |
| New patient office visit, complex (60-74 min) | 63 | $168 | $250 |
| Lower back and sciatic nerve injection An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site. |
62 | $169 | $292 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $64 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $136 | $225 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
39 | $170 | $410 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
33 | $49 | $120 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $55 | $100 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
20 | $356 | $735 |
| Tendon injection at attachment site A procedure involving the injection of medication into a tendon where it attaches to bone or muscle. |
18 | $45 | $95 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
17 | $233 | $525 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
14 | $77 | $125 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
12 | $109 | $256 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
12 | $202 | $460 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,485
Total received (2018-2024)
Avg $3,498/year across 7 years
Top 14% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
1,379
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,475 (83.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,775 (11.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,235 (5.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,442
2023
$3,009
2022
$3,951
2021
$3,778
2020
$2,549
2019
$4,299
2018
$2,457
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$542
Neurocrine Biosciences, Inc.
$413
Amneal Pharmaceuticals LLC
$390
ABBVIE INC.
$357
EMD Serono, Inc.
$306
Teva Pharmaceuticals USA, Inc.
$297
Novartis Pharmaceuticals Corporation
$258
PFIZER INC.
$234
Biogen, Inc.
$213
Neurelis, Inc.
$177
ARGENX US, INC.
$156
SK Life Science, Inc.
$152
Takeda Pharmaceuticals U.S.A., Inc.
$146
Celgene Corporation
$138
Eisai Inc.
$90
CATALYST PHARMACEUTICALS, INC.
$90
JAZZ PHARMACEUTICALS INC.
$73
Lilly USA, LLC
$71
MITSUBISHI TANABE PHARMA AMERICA, INC.
$46
MDD US Operations, LLC
$44
Otsuka America Pharmaceutical, Inc.
$37
Octapharma USA, Inc.
$34
Sumitomo Pharma America, Inc.
$34
Lundbeck LLC
$27
Alexion Pharmaceuticals, Inc.
$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$24
Aucta Pharmaceuticals, Inc.
$23
Grifols USA, LLC
$18
Genentech USA, Inc.
$16
Cycle Pharmaceuticals Inc
$10
Top 3 companies account for 30.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amneal Pharmaceuticals LLC
$2,934
UCB, Inc.
$2,274
Teva Pharmaceuticals USA, Inc.
$1,576
ARGENX US, INC.
$1,566
Novartis Pharmaceuticals Corporation
$1,454
Biogen, Inc.
$1,018
Neurocrine Biosciences, Inc.
$1,004
GENZYME CORPORATION
$937
EMD Serono, Inc.
$875
ABBVIE INC.
$695
PFIZER INC.
$630
Lilly USA, LLC
$573
SK Life Science, Inc.
$530
Celgene Corporation
$489
Eisai Inc.
$438
Sunovion Pharmaceuticals Inc.
$435
Amgen Inc.
$405
AbbVie Inc.
$369
Avanir Pharmaceuticals, Inc.
$368
Lundbeck LLC
$363
IMPEL PHARMACEUTICALS INC.
$356
Adamas Pharmaceuticals, Inc.
$330
Neurelis, Inc.
$325
Vanda Pharmaceuticals Inc.
$322
Supernus Pharmaceuticals, Inc.
$319
Acorda Therapeutics, Inc
$275
Allergan, Inc.
$255
Takeda Pharmaceuticals U.S.A., Inc.
$248
Sumitomo Pharma America, Inc.
$177
Alexion Pharmaceuticals, Inc.
$175
Kyowa Kirin, Inc.
$173
Janssen Pharmaceuticals, Inc
$148
E.R. Squibb & Sons, L.L.C.
$148
CATALYST PHARMACEUTICALS, INC.
$145
Biohaven Pharmaceutical Holding Company Ltd.
$136
Bayer HealthCare Pharmaceuticals Inc.
$133
JAZZ PHARMACEUTICALS INC.
$124
AbbVie, Inc.
$115
AQUESTIVE THERAPEUTICS, INC.
$110
EISAI INC.
$109
MDD US Operations, LLC
$92
MITSUBISHI TANABE PHARMA AMERICA, INC.
$89
Horizon Therapeutics plc
$88
Corium, LLC
$84
ACADIA Pharmaceuticals Inc
$84
Greenwich Biosciences, Inc.
$81
Otsuka America Pharmaceutical, Inc.
$79
Biohaven Pharmaceuticals, Inc.
$76
Vertical Pharmaceuticals, LLC
$57
Impax Laboratories, Inc.
$56
Allergan Inc.
$53
Mitsubishi Tanabe Pharma America, Inc.
$45
Zogenix Inc.
$43
Aprecia Pharmaceuticals, LLC
$40
Avion Pharmaceuticals
$40
Genentech USA, Inc.
$36
Octapharma USA, Inc.
$34
UPSHER-SMITH LABORATORIES LLC
$34
GE HEALTHCARE
$32
SANOFI-AVENTIS U.S. LLC
$27
Merz North America, Inc.
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$24
Aucta Pharmaceuticals, Inc.
$23
Alnylam Pharmaceuticals Inc.
$21
CSL Behring
$20
Amylyx Pharmaceuticals, Inc.
$19
Bausch Health US, LLC
$19
Upsher-Smith Laboratories LLC
$18
Grifols USA, LLC
$18
Exeltis, USA Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
Catalyst Pharmaceuticals, Inc.
$14
Mylan Pharmaceuticals Inc.
$13
Cycle Pharmaceuticals Inc
$10
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BOTOX · Betaseron · Briviact · CAPLYTA · COMIRNATY · COPAXONE · CREXONT · DIVIGEL · DUOPA · Dayvigo · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FYCOMPA · Fabhalta · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · HETLIOZ · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MOVANTIK · Mavenclad · Motpoly XR · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · ONFI · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · RELYVRIO · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SYMPAZAN · SYNVISC-ONE · Soliris · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · XEOMIN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
269
Per 100K population
21.1
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE HOSPITAL, SOUTHFIELD AND NOVI
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gilbert is a mixed practice specialist, with above-average Medicare volume (top 5% in MI), with low-engagement industry engagement in the top 14% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gilbert experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Gilbert performed 4,090 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gilbert receive payments from pharmaceutical companies?
Yes. Dr. Gilbert received a total of $24,485 from 74 companies across 1,379 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gilbert's costs compare to other neurologists in Lathrup Village?
Dr. Gilbert's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gilbert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Lathrup Village
Browse neurologists in Lathrup Village ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Amneal Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Amneal Pharmaceuticals LLC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology